Ribavirin Teva Pharma B.V. Ευρωπαϊκή Ένωση - Δανικά - EMA (European Medicines Agency)

ribavirin teva pharma b.v.

teva b.v. - ribavirin - hepatitis c kronisk - antivirale midler til systemisk anvendelse - ribavirin teva pharma b. is indicated in combination with other medicinal products for the treatment ofchronic hepatitis c (chc) in adults (see sections 4. 2, 4. 4 og 5. ribavirin teva pharma b. is indicated in combination with other medicinal products for the treatment ofchronic hepatitis c (chc) for paediatric patients (children 3 years of age and older and adolescents) notpreviously treated and without liver decompensation (see sections 4. 2, 4. 4 og 5.

Buprenorphin/Naloxon "G.L. Pharma" 2+0,5 mg resoribletter, sublinguale Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

buprenorphin/naloxon "g.l. pharma" 2+0,5 mg resoribletter, sublinguale

g.l. pharma gmbh - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 2+0,5 mg